AHR and metabolic syndrome: However, metabolic syndromes, such as obesity, diabetes, and high blood pressure of humans and animal models exhibit reduced AHR agonist activity, as shown by lower gut microbiota-derived AHR agonist production, such as of tryptophan metabolites (22).